Zhejiang Hisoar Pharmaceutical: Announcement on the completion of the implementation of the director's shareholding plan.
Zhejiang Hisoar Pharmaceutical: Announcement regarding the release of pledges on stocks by major shareholders.
Zhejiang Hisoar Pharmaceutical: Announcement on stock pledged repurchase trade for partial stocks of major shareholders.
Zhejiang Hisoar Pharmaceutical: An indicative announcement on the duration and sale of the 2020 Employee Stock Ownership Plan
Zhejiang Hisoar Pharmaceutical: Announcement on the progress of the Chairman's plan to increase holdings
Zhejiang Hisoar Pharmaceutical: Announcement on the completion of the implementation of share repurchases and changes in shares
Haixiang Pharmaceutical: Announcement on the progress of share repurchases
Haixiang Pharmaceutical: Announcement on the progress of share repurchases
Haixiang Pharmaceutical: Announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions for share repurchases
Haixiang Pharmaceutical: Announcement on the number of shares repurchased exceeding 1% of the total share capital
Haixiang Pharmaceutical: Announcement on the initial repurchase of the company\'s shares
Haixiang Pharmaceutical: An indicative announcement on increasing the total capital for share repurchase
Haixiang Pharmaceutical: Announcement on the share repurchase plan
Haixiang Pharmaceutical: Repurchase Report
Haixiang Pharmaceutical: Announcement on the Chairman\'s Plan to Increase Shares in the Company
Haixiang Pharmaceutical: Announcement on the Chairman\'s Proposal to Repurchase the Company\'s Shares
Haixiang Pharmaceutical: Announcement on the majority shareholders\' processing of stock pledged repurchase deferred business
Haixiang Pharmaceutical: Prompt Announcement on the Duration of the 2020 Employee Stock Ownership Plan
Haixiang Pharmaceutical: 2022 Annual Equity Distribution Implementation Notice
Haixiang Pharmaceutical: Shareholder Dividend Return Plan for the Next Three Years (2023-2025)
No Data
No Data